MedTrace Logo

Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA

NCT01654783 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5704

Last updated 2015-02-18

No results posted yet for this study

Summary

The objectives of this study are to investigate how oral 5-ASA drugs have been used in the condition without symptoms such as abdominal pain or diarrhea/bloody stool (remission stage), or in the transition from the condition with symptoms such as abdominal pain or diarrhea/bloody stool (active stage) to the remission stage in ulcerative colitis and to study how many patients will be able to maintain the remission stage during the observation period and how many times the patients will experience the active stage (relapse), as well as how symptoms will change during the observation period to discover better treatment plans.

Conditions

Sponsors & Collaborators

  • Kyorin Pharmaceutical Co.,Ltd

    lead INDUSTRY

Principal Investigators

  • Soji Omuro, Mr. · Kyorin Pharmaceutical Co.,Ltd

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • Japan

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01654783 on ClinicalTrials.gov